I 
119TH CONGRESS 
1ST SESSION H. R. 3032 
To ensure appropriate access to remote monitoring services furnished under 
the Medicare program. 
IN THE HOUSE OF REPRESENTATIVES 
APRIL 28, 2025 
Mr. BALDERSON (for himself, Mr. DUNN of Florida, and Mr. MURPHY) intro-
duced the following bill; which was referred to the Committee on Energy 
and Commerce, and in addition to the Committee on Ways and Means, 
for a period to be subsequently determined by the Speaker, in each case 
for consideration of such provisions as fall within the jurisdiction of the 
committee concerned 
A BILL 
To ensure appropriate access to remote monitoring services 
furnished under the Medicare program. 
Be it enacted by the Senate and House of Representa-
tives of the United States of America in Congress assembled, 
SECTION 1. SHORT TITLE. 
This Act may be cited as the ‘‘Expanding Remote 
Monitoring Access Act’’. 
SEC. 2. FINDINGS. 
The Congress finds the following: 
VerDate Sep 11 2014 
09:01 May 06, 2025
Jkt 000000
PO 00000
Frm 00001
Fmt 6652
Sfmt 6201
E:\BILLS\H3032.IH
H3032
mprince on LAP1J3WLY3PROD with $$_JOB
(1) Remote monitoring is an option that can 
help patients manage their health conditions from 
their homes with oversight from their health care 
providers, which can improve patient health out-
comes, reduce long-term health costs, and increase 
care options for patients. 
(2) The Department of Veterans Affairs (VA) 
saw such results in a 2019 report. Veterans enrolled 
in remote patient monitoring had a 53 percent de-
crease in VA bed days of care and a 33 percent de-
crease in VA hospital admissions. 
(3) Providers are currently required by Medi-
care to collect 16 days of patient data over a 30-day 
period in order to bill Medicare for remote moni-
toring services, even in cases where this full duration 
is not medically necessary to ensure the health and 
safety of the patient. This can limit the use of re-
mote monitoring in instances where it can promote 
patient health and safety and where it can reduce 
the overall cost on the health system. 
(4) In the 2021 Physician Fee Schedule, the 
Centers for Medicare and Medicaid Services (CMS) 
issued an interim policy to lower the duration re-
quired by Medicare to bill for remote monitoring 
services from 16 days to 2 days within a 30-day pe-
VerDate Sep 11 2014 
09:01 May 06, 2025
Jkt 000000
PO 00000
Frm 00002
Fmt 6652
Sfmt 6201
E:\BILLS\H3032.IH
H3032
mprince on LAP1J3WLY3PROD with $$_JOB
riod, but only for individuals who had been diag-
nosed with, or were suspected of having, COVID–19. 
This short-term flexibility called attention to the 
long-term need to reassess the minimum duration 
required for providers to bill for remote monitoring. 
(5) As part of issuing the 2021 Physician Fee 
Schedule, CMS studied comments in support of per-
manently lowering the minimum required duration 
of remote monitoring for all patients, not just those 
with COVID–19. 
(6) CMS concluded that ‘‘we agree that a full 
16 days of monitoring may not always be reasonable 
and necessary’’ but did not revise the 16 day per 30- 
day period minimum duration for all patients be-
cause CMS did not believe they had received ‘‘spe-
cific clinical examples’’ to allow for ‘‘understanding 
under what clinical circumstances fewer days of 
monitoring would be medically reasonable and nec-
essary and allow a practitioner to establish clinically 
meaningful care’’. 
(7) Clinical evidence shows numerous instances 
in which fewer than sixteen days of monitoring with-
in a 30-day period establishes clinically meaningful 
care. These include: 
VerDate Sep 11 2014 
09:01 May 06, 2025
Jkt 000000
PO 00000
Frm 00003
Fmt 6652
Sfmt 6201
E:\BILLS\H3032.IH
H3032
mprince on LAP1J3WLY3PROD with $$_JOB
(A) Sixteen days of monitoring per 30-day 
period may not be required to establish that a 
patient has sleep apnea. 
(B) A patient prescribed a narcotic for 
pain may require their breathing to be mon-
itored only while on the medication. 
(C) A patient with a chronic condition like 
diabetes, congestive heart failure, or obesity 
may have their weight monitored over a longer 
period of time, but it is not clinically appro-
priate to have such patient step on a scale 16 
or more times in each 30-day period. 
(D) A patient whose blood pressure or oxy-
gen levels are monitored during physical ther-
apy may not necessitate 16 days of monitoring 
in each 30-day period given physical therapy is 
often ordered twice weekly. 
(E) A patient who wears a heart monitor 
to measure palpitations may wear the monitor 
continuously, but the data only needs to be col-
lected when the individual is experiencing symp-
toms. 
(F) A patient with hypertension is often 
monitored for long-term management of this 
condition on more of a weekly basis, only need-
VerDate Sep 11 2014 
09:01 May 06, 2025
Jkt 000000
PO 00000
Frm 00004
Fmt 6652
Sfmt 6201
E:\BILLS\H3032.IH
H3032
mprince on LAP1J3WLY3PROD with $$_JOB